PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+13.59%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$11.5B
AUM Growth
+$11.5B
(+5.5%)
Cap. Flow
-$598M
Cap. Flow
% of AUM
-5.2%
Top 10 Holdings %
Top 10 Hldgs %
26.57%
Holding
326
New
47
Increased
82
Reduced
126
Closed
45
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$67.4M |
| 2 |
Zimmer Biomet
ZBH
|
$61.7M |
| 3 |
Stryker
SYK
|
$61.3M |
| 4 |
HCA Healthcare
HCA
|
$56.9M |
| 5 |
US Foods
USFD
|
$51M |
Top Sells
| 1 |
ServiceNow
NOW
|
$68.9M |
| 2 |
Expedia Group
EXPE
|
$67.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$60M |
| 4 |
Edwards Lifesciences
EW
|
$57.8M |
| 5 |
Danaher
DHR
|
$50.5M |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Financials | 22.37% |
| 3 | Healthcare | 17.75% |
| 4 | Communication Services | 10.21% |
| 5 | Consumer Discretionary | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
176
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.6M | 0.1% |
104,505
-19,895
| -16% | -$2.21M |
|
177
Heritage Insurance Holdings
HRTG
$706M
| $11.3M | 0.1% |
850,000
-140,000
| -14% | -$1.86M |
|
178
Medtronic
MDT
$119B
| $11M | 0.1% |
96,598
+6,444
| +7% | +$731K |
|
179
Wheaton Precious Metals
WPM
$45.6B
| $10.7M | 0.09% |
+358,556
| New | +$10.7M |
|
|
MYOK
180
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.6M | 0.09% |
145,000
-205,000
| -59% | -$14.9M |
|
181
Wells Fargo
WFC
$263B
| $10.5M | 0.09% |
194,316
-685
| -0.4% | -$36.9K |
|
182
Blackstone
BX
$134B
| $10.3M | 0.09% |
184,151
-22,100
| -11% | -$1.24M |
|
183
Ares Capital
ARCC
$15.8B
| $10.2M | 0.09% |
549,050
-121,950
| -18% | -$2.27M |
|
184
BioMarin Pharmaceuticals
BMRN
$11.2B
| $10.1M | 0.09% |
120,000
-5,000
| -4% | -$423K |
|
|
FRC
185
DELISTED
First Republic Bank
FRC
| $10.1M | 0.09% |
86,090
-15,782
| -15% | -$1.85M |
|
186
US Bancorp
USB
$76B
| $9.97M | 0.09% |
168,089
+6,887
| +4% | +$408K |
|
187
Revvity
RVTY
$10.5B
| $9.39M | 0.08% |
96,669
-13,331
| -12% | -$1.29M |
|
188
Thermo Fisher Scientific
TMO
$186B
| $9.27M | 0.08% |
28,528
-5,692
| -17% | -$1.85M |
|
189
East-West Bancorp
EWBC
$14.5B
| $9.16M | 0.08% |
188,034
+53,191
| +39% | +$2.59M |
|
|
XENT
190
DELISTED
Intersect ENT, Inc
XENT
| $9.1M | 0.08% |
+365,339
| New | +$9.1M |
|
|
TPTX
191
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.03M | 0.08% |
+145,000
| New | +$9.03M |
|
|
AMRN
192
Amarin Corp
AMRN
$311M
| $8.58M | 0.07% |
400,000
-350,000
| -47% | -$7.5M |
|
193
Rockwell Automation
ROK
$38.6B
| $8.14M | 0.07% |
40,149
-2,534
| -6% | -$514K |
|
194
SLR Investment Corp
SLRC
$907M
| $7.72M | 0.07% |
374,550
-111,978
| -23% | -$2.31M |
|
195
Y-mAbs Therapeutics
YMAB
$388M
| $7.66M | 0.07% |
245,000
+229,498
| +1,480% | +$7.17M |
|
196
Atlassian
TEAM
$46.6B
| $7.54M | 0.07% |
62,647
+22,020
| +54% | +$2.65M |
|
197
Enterprise Financial Services Corp
EFSC
$2.27B
| $7.46M | 0.06% |
154,748
+18,098
| +13% | +$872K |
|
|
SIVB
198
DELISTED
SVB Financial Group
SIVB
| $7.35M | 0.06% |
29,283
+1,667
| +6% | +$418K |
|
199
uniQure
QURE
$896M
| $7.17M | 0.06% |
+100,000
| New | +$7.17M |
|
200
Ascendis Pharma
ASND
$11.8B
| $6.96M | 0.06% |
50,000
+25,000
| +100% | +$3.48M |
|